Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_assertion type Assertion NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_head.
- NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_assertion description "[The von Hippel-Lindau (VHL) tumour suppressorgene product is believed to be involved in the down-regulation of transcriptional elongation by preventing the association of elongin B and C with the catalytic subunit elongin A. Alterations in the human VHL gene lead to VHL disease which is associated with various rare neoplasias, including haemangioblastoma of the central nervous system, retinal angioma, clear cell renal carcinoma and pheochromocytoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_provenance.
- NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_assertion evidence source_evidence_literature NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_provenance.
- NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_assertion SIO_000772 9931330 NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_provenance.
- NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_assertion wasDerivedFrom befree-20150227 NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_provenance.
- NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_assertion wasGeneratedBy ECO_0000203 NP724317.RAO6woLRZT1m68iY3LP4LZjBrQU0pRQUA-CW2MPqMzIAo130_provenance.